|
End-of-day quote
Nasdaq
27/10/2026
|
5-day change | 1st Jan Change | ||
| 1.550 USD | -1.90% |
|
-4.91% | -82.83% |
| 10-16 | EnGene Therapeutics Inc. - Special Call | |
| 09-21 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
| Market Cap | 106M 95M 87.83M 79.55M 149M 10.08B 150M 1.05B 418M 5.28B 397M 389M 16.75B | P/E 2026 * |
-0.86x | P/E 2027 * | -1.04x |
|---|---|---|---|---|---|
| Enterprise Value | -78.64M -70.55M -65.23M -59.08M -110M -7.49B -112M -780M -311M -3.92B -295M -289M -12.44B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 5.61x |
| Free-Float |
99.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
CBOE
| ENGN | Real-time | |
|
Deutsche Boerse AG
| S0N0 | Delayed |
Last Transcript: enGene Therapeutics Inc.
| 1 day | -1.90% | ||
| 1 week | -4.91% | ||
| Current month | -22.50% | ||
| 1 month | -21.32% | ||
| 3 months | -11.93% | ||
| 6 months | -77.73% | ||
| Current year | -82.83% |
| 1 week | 1.54 |  | 1.62 |
| 1 month | 1.54 | | 2.02 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 43 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 63 | 22/07/2024 |
Kathleen Richton
DFI | Director of Finance/CFO | 48 | 16/07/2026 |
William Grossman
CTO | Chief Tech/Sci/R&D Officer | 56 | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Brunk
BRD | Director/Board Member | 57 | 08/08/2023 |
Lota Zoth
BRD | Director/Board Member | 66 | 18/12/2023 |
Paul Hastings
BRD | Director/Board Member | 66 | 15/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/9/26 | Buy | Chief Technology Officer | 5,102 | 0.0076% | ||
| 16/7/26 | Other | Interim Chief Business Officer | 75,000 | 0.1120% | ||
| 16/7/26 | Other | Chief Financial Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -4.91% | -80.40% | -94.55% | 104M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +81.21% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +100.19% | 53.59B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 44.75B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 41.62B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +92.73% | 26.7B | |
| +3.72% | -6.23% | +26.01% | -2.99% | 23.36B | |
| Average | +3.91% | -0.87% | +39.04% | +137.09% | 38.05B | |
| Weighted average by Cap. | +3.23% | -0.29% | +47.62% | +161.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5.6M 5.02M 4.64M 4.2M 7.85M 533M 7.95M 55.51M 22.11M 279M 21M 20.56M 885M |
| Net income | -124M -112M -103M -93.52M -175M -11.86B -177M -1.23B -492M -6.2B -467M -457M -19.69B | -113M -101M -93.32M -84.52M -158M -10.71B -160M -1.12B -444M -5.61B -422M -413M -17.8B |
| Net Debt | -185M -166M -153M -139M -259M -17.57B -262M -1.83B -729M -9.2B -692M -678M -29.19B | -74.46M -66.81M -61.77M -55.94M -105M -7.09B -106M -739M -294M -3.71B -279M -274M -11.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$1.580 | +1.94% | 997,365 |
| 27/10/26 | US$1.550 | -1.90% | 365,261 |
| 26/10/26 | US$1.580 | +1.28% | 657,823 |
| 23/10/26 | US$1.560 | -1.27% | 730,199 |
| 22/10/26 | US$1.580 | -3.07% | 554,578 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ENGN Stock
Select your edition
All financial news and data tailored to specific country editions
